Kirjallinen kysymys Fimean alueellistamisesta

This procedure is a written parliamentary question regarding the potential regionalization of Fimea, the Finnish Medicines Agency. It seeks to clarify how the agency's operations are organized and whether shifting functions to different regions would impact its efficiency or the business environment. The outcome may affect pharmaceutical companies, healthcare providers, and regional administrations in Finland by changing how regulatory oversight and licensing are managed.